Voyager Therapeutics, Inc.
Profit Margins
| Period | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| Mar 2015 | — | -187.4% | -565.9% |
| Jun 2015 | — | -81.2% | -79.8% |
| Sep 2015 | — | -81.4% | -79.3% |
| Dec 2015 | — | -150.7% | -178.6% |
| Mar 2016 | — | -154.6% | -148.8% |
| Jun 2016 | — | -258.5% | -250.9% |
| Sep 2016 | — | -313.5% | -271.9% |
| Dec 2016 | — | -586.1% | -621.3% |
| Mar 2017 | — | -1,196.9% | -1,137.2% |
| Jun 2017 | — | -1,583.6% | -1,603.7% |
| Sep 2017 | — | -2,034.4% | -2,033.6% |
| Dec 2017 | — | -194.6% | -186.4% |
| Mar 2018 | — | -2,239.2% | -2,115.3% |
| Jun 2018 | — | -997.8% | -991.9% |
| Sep 2018 | — | -1,009.9% | -968.9% |
| Dec 2018 | — | -1,153.4% | -1,122.1% |
| Mar 2019 | — | -563.7% | -522.8% |
| Jun 2019 | — | 19.9% | 24.2% |
| Sep 2019 | — | -87.1% | -73.4% |
| Dec 2019 | — | -42.1% | -38.5% |
| Mar 2020 | — | -135.2% | -134.3% |
| Jun 2020 | — | -31.3% | -30.3% |
| Sep 2020 | — | 71.7% | 72.6% |
| Dec 2020 | — | -363.0% | -243.6% |
| Mar 2021 | — | -393.6% | -333.0% |
| Jun 2021 | — | -2,106.5% | -2,219.6% |
| Sep 2021 | — | -1,696.8% | -1,696.2% |
| Dec 2021 | — | 20.3% | 20.3% |
| Mar 2022 | — | -3,244.7% | -3,240.0% |
| Jun 2022 | — | -2,720.1% | -2,680.8% |
| Sep 2022 | — | 35.2% | 42.9% |
| Dec 2022 | — | 1,585.7% | 1,525.2% |
| Mar 2023 | — | 81.7% | 82.4% |
| Jun 2023 | — | -523.9% | -457.6% |
| Sep 2023 | — | -639.5% | -561.4% |
| Dec 2023 | — | 60.0% | 62.6% |
| Mar 2024 | — | -82.9% | -58.1% |
| Jun 2024 | — | -50.8% | -34.3% |
| Sep 2024 | — | -56.0% | -36.7% |
| Dec 2024 | — | -610.1% | -549.3% |
| Mar 2025 | — | -536.0% | -479.2% |
| Jun 2025 | — | -704.3% | -642.0% |
| Sep 2025 | — | -228.9% | -208.7% |
| Dec 2025 | — | -195.2% | -178.8% |
| Mar 2026 | — | -1,167.4% | -1,077.4% |
| Jun 2026 | — | -833.9% | -773.2% |